Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17888022rdf:typepubmed:Citationlld:pubmed
pubmed-article:17888022lifeskim:mentionsumls-concept:C0032460lld:lifeskim
pubmed-article:17888022lifeskim:mentionsumls-concept:C0039601lld:lifeskim
pubmed-article:17888022lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:17888022lifeskim:mentionsumls-concept:C0202228lld:lifeskim
pubmed-article:17888022lifeskim:mentionsumls-concept:C0202227lld:lifeskim
pubmed-article:17888022lifeskim:mentionsumls-concept:C0428629lld:lifeskim
pubmed-article:17888022lifeskim:mentionsumls-concept:C0935763lld:lifeskim
pubmed-article:17888022lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:17888022pubmed:issue3lld:pubmed
pubmed-article:17888022pubmed:dateCreated2008-2-22lld:pubmed
pubmed-article:17888022pubmed:abstractTextHyperandrogenaemia is one of the three Rotterdam consensus diagnostic criteria for polycystic ovarian syndrome (PCOS) and may be measured by estimation of total testosterone, free androgen index (FAI) or bioavailable testosterone (BioT). The aim of this study was to compare the biological variability of total testosterone with that of the biological variability of both the FAI and BioT, to determine the least variable measurement for clinical practice.lld:pubmed
pubmed-article:17888022pubmed:languageenglld:pubmed
pubmed-article:17888022pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17888022pubmed:citationSubsetIMlld:pubmed
pubmed-article:17888022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17888022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17888022pubmed:statusMEDLINElld:pubmed
pubmed-article:17888022pubmed:monthMarlld:pubmed
pubmed-article:17888022pubmed:issn1365-2265lld:pubmed
pubmed-article:17888022pubmed:authorpubmed-author:DiverM JMJlld:pubmed
pubmed-article:17888022pubmed:authorpubmed-author:HANT HTHlld:pubmed
pubmed-article:17888022pubmed:authorpubmed-author:KilpatrickE...lld:pubmed
pubmed-article:17888022pubmed:authorpubmed-author:AtkinS LSLlld:pubmed
pubmed-article:17888022pubmed:authorpubmed-author:JayagopalVVlld:pubmed
pubmed-article:17888022pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17888022pubmed:volume68lld:pubmed
pubmed-article:17888022pubmed:ownerNLMlld:pubmed
pubmed-article:17888022pubmed:authorsCompleteYlld:pubmed
pubmed-article:17888022pubmed:pagination390-4lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:meshHeadingpubmed-meshheading:17888022...lld:pubmed
pubmed-article:17888022pubmed:year2008lld:pubmed
pubmed-article:17888022pubmed:articleTitleBiological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.lld:pubmed
pubmed-article:17888022pubmed:affiliationDepartment of Medicine, University of Hull, UK. l.cho@hull.ac.uklld:pubmed
pubmed-article:17888022pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17888022lld:pubmed